Success Stories: EB-1A Approved for a Toxicologist in California in the Field of Pharmacology & Toxicology
Client’s Testimonial:
This is a great firm that specializes in employment-based immigrant visas and are experts at handling EB1A cases. I would highly recommend anyone thinking about EB or NIW applications to consult with this firm. Their personalized handling of your case and quick response time is phenomenal. Highly Recommended. Thanks again to all the lawyers and especially WeGreened.com's Attorney Chen for handling my case.
On January 28th, 2015, We Received Another EB1-A (Alien of Extraordinary Ability) Approval for a Toxicologist in the Field of Pharmacology & Toxicology (Approval Notice)
Position at the Time of Case Filing: Toxicologist
Country of Origin: India
Service Center: Nebraska Service Center (NSC)
State of Residence at the Time of Filing: California
Approval Notice Date: January 28th, 2015
Processing Time: 5 months, 13 days
A toxicology researcher from India who worked in pharmacology & toxicology was our client in this case. His specialized research had focused on the bioenergetics and mitochondrial function and toxicity in neurodegenerative disorders, alcoholism, obesity, smoking, and diabetes. His body of work comprised 11 peer-reviewed scientific articles and numerous presentations at national and international conferences; by the time we filed his case, his research had received no fewer than 178 citations from independent and leading researchers at prestigious institutions and organizations around the world, a strong indication of the major significance of his work. He has also performed peer-review service for 13 distinctive, internationally-circulated journals, reviewing at least 18 manuscripts. An independent recommender attested to our client’s superior expertise: “As an expert in the field of cellular neuroscience, I testify that [Client’s] identification of the capacity of lipoic acid to promote glucose uptake in the brain and, in doing so, bolster synaptic plasticity in a mouse model of Alzheimer's disease, has generated animated discussion throughout the field. [Client’s] research clearly supports the imminent need to generate larger clinical trials and catalyze the production of therapeutic agents enriched with lipoic acid to prevent and treat Alzheimer's disease.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of Pharmacology & Toxicology, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in 5 months and 13 days.